These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 14688067)

  • 1. Mouse CD20 expression and function.
    Uchida J; Lee Y; Hasegawa M; Liang Y; Bradney A; Oliver JA; Bowen K; Steeber DA; Haas KM; Poe JC; Tedder TF
    Int Immunol; 2004 Jan; 16(1):119-29. PubMed ID: 14688067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The peritoneal cavity provides a protective niche for B1 and conventional B lymphocytes during anti-CD20 immunotherapy in mice.
    Hamaguchi Y; Uchida J; Cain DW; Venturi GM; Poe JC; Haas KM; Tedder TF
    J Immunol; 2005 Apr; 174(7):4389-99. PubMed ID: 15778404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B-cell depletion using an anti-CD20 antibody augments antitumor immune responses and immunotherapy in nonhematopoetic murine tumor models.
    Kim S; Fridlender ZG; Dunn R; Kehry MR; Kapoor V; Blouin A; Kaiser LR; Albelda SM
    J Immunother; 2008 Jun; 31(5):446-57. PubMed ID: 18463540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody isotype-specific engagement of Fcgamma receptors regulates B lymphocyte depletion during CD20 immunotherapy.
    Hamaguchi Y; Xiu Y; Komura K; Nimmerjahn F; Tedder TF
    J Exp Med; 2006 Mar; 203(3):743-53. PubMed ID: 16520392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of dense human tonsilar B cells. Induction of c-myc gene expression via two distinct signal transduction pathways.
    White MW; McConnell F; Shu GL; Morris DR; Clark EA
    J Immunol; 1991 Feb; 146(3):846-53. PubMed ID: 1703181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type I CD20 Antibodies Recruit the B Cell Receptor for Complement-Dependent Lysis of Malignant B Cells.
    Engelberts PJ; Voorhorst M; Schuurman J; van Meerten T; Bakker JM; Vink T; Mackus WJ; Breij EC; Derer S; Valerius T; van de Winkel JG; Parren PW; Beurskens FJ
    J Immunol; 2016 Dec; 197(12):4829-4837. PubMed ID: 27807190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maintenance of long-lived plasma cells and serological memory despite mature and memory B cell depletion during CD20 immunotherapy in mice.
    DiLillo DJ; Hamaguchi Y; Ueda Y; Yang K; Uchida J; Haas KM; Kelsoe G; Tedder TF
    J Immunol; 2008 Jan; 180(1):361-71. PubMed ID: 18097037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fcgamma receptor-dependent effector mechanisms regulate CD19 and CD20 antibody immunotherapies for B lymphocyte malignancies and autoimmunity.
    Tedder TF; Baras A; Xiu Y
    Springer Semin Immunopathol; 2006 Dec; 28(4):351-64. PubMed ID: 17091246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD83 Antibody Inhibits Human B Cell Responses to Antigen as well as Dendritic Cell-Mediated CD4 T Cell Responses.
    Wong KY; Baron R; Seldon TA; Jones ML; Rice AM; Munster DJ
    J Immunol; 2018 May; 200(10):3383-3396. PubMed ID: 29643191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction and characterization of monoclonal antibodies against the extracellular domain of B-lymphocyte antigen CD20 using DNA immunization method.
    Khademi F; Mostafaie A; Parvaneh S; Gholami Rad F; Mohammadi P; Bahrami G
    Int Immunopharmacol; 2017 Feb; 43():23-32. PubMed ID: 27939822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody-mediated B-cell depletion before adoptive immunotherapy with T cells expressing CD20-specific chimeric T-cell receptors facilitates eradication of leukemia in immunocompetent mice.
    James SE; Orgun NN; Tedder TF; Shlomchik MJ; Jensen MC; Lin Y; Greenberg PD; Press OW
    Blood; 2009 Dec; 114(27):5454-63. PubMed ID: 19880489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD20 homo-oligomers physically associate with the B cell antigen receptor. Dissociation upon receptor engagement and recruitment of phosphoproteins and calmodulin-binding proteins.
    Polyak MJ; Li H; Shariat N; Deans JP
    J Biol Chem; 2008 Jul; 283(27):18545-52. PubMed ID: 18474602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD20 monoclonal antibodies down-regulate IgM at the surface of B cells.
    Bourget I; Breittmayer JP; Grenier-Brossette N; Cousin JL
    Eur J Immunol; 1993 Mar; 23(3):768-71. PubMed ID: 7680616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-CD20 treatment depletes B-cells in blood and lymphatic tissue of cynomolgus monkeys.
    Schröder C; Azimzadeh AM; Wu G; Price JO; Atkinson JB; Pierson RN
    Transpl Immunol; 2003; 12(1):19-28. PubMed ID: 14551029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A member of the tetra spans transmembrane protein superfamily is recognized by a monoclonal antibody raised against an HLA class I-deficient, lymphokine-activated killer-susceptible, B lymphocyte line. Cloning and preliminary functional studies.
    Gil ML; Vita N; Lebel-Binay S; Miloux B; Chalon P; Kaghad M; Marchiol-Fournigault C; Conjeaud H; Caput D; Ferrara P
    J Immunol; 1992 May; 148(9):2826-33. PubMed ID: 1573270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-CD20- and B-cell receptor-mediated apoptosis: evidence for shared intracellular signaling pathways.
    Mathas S; Rickers A; Bommert K; Dörken B; Mapara MY
    Cancer Res; 2000 Dec; 60(24):7170-6. PubMed ID: 11156427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced T-dependent humoral immunity in CD20-deficient mice.
    Morsy DE; Sanyal R; Zaiss AK; Deo R; Muruve DA; Deans JP
    J Immunol; 2013 Sep; 191(6):3112-8. PubMed ID: 23966626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-CD3ε induces splenic B220lo B-cell expansion following anti-CD20 treatment in a mouse model of allosensitization.
    Todo T; Wu G; Chai NN; He Y; Martins G; Gupta A; Fair J; Liu NY; Jordan S; Klein A
    Int Immunol; 2012 Aug; 24(8):529-38. PubMed ID: 22531063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The innate mononuclear phagocyte network depletes B lymphocytes through Fc receptor-dependent mechanisms during anti-CD20 antibody immunotherapy.
    Uchida J; Hamaguchi Y; Oliver JA; Ravetch JV; Poe JC; Haas KM; Tedder TF
    J Exp Med; 2004 Jun; 199(12):1659-69. PubMed ID: 15210744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional studies on B cell hybridomas with B cell surface antigens. I. Effects of anti-immunoglobulin antibodies on proliferation and differentiation.
    Hamano T; Asofsky R
    J Immunol; 1983 May; 130(5):2027-32. PubMed ID: 6403617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.